Minerva Neurosciences, Inc (NASDAQ:NERV)
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company’s pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD) & insomnia, and Parkinson’s disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Minerva Neurosciences, Inc (NASDAQ:NERV)’s Financial Overview
Minerva Neurosciences, Inc (NASDAQ) declined -0.26% yesterday to close its trading session at $7.59. The company has 1 year Price Target of $19. Minerva Neurosciences, Inc has 52-Week high of $12.95 and 52-Week Low of $5. The stock touched its 52-Week High on 12.95 and 52-Week Low on 5.00. The stock traded with the volume of 70831 shares yesterday. The firm shows the market capitalization of $295.78 Million.
Minerva Neurosciences, Inc (NASDAQ) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $-0.31/share against the analyst consensus estimate of $-0.38/share. The difference between the actual and expected EPS is $0.07 a share with a surprise factor of 18.4%.
The firm is trading with SMA20 of 8.37 Percent, SMA50 of -7.39 Percent and SMA200 of -11.89 percent. Minerva Neurosciences, Inc has P/S value of 0 while its P/B value stands at 2.91. Similarly, the company has Return on Assets of -22 percent, Return on Equity of -31.7 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 0 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 3 analysts offering 12-month price forecasts for Minerva Neurosciences Inc have a median target of 19.00, with a high estimate of 20.00 and a low estimate of 18.00. The median estimate represents a +150.33% increase from the last price of 7.59.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
Aquantia Corp. (NYSE:AQ)
Aquantia Corp. is engaged in design, development and marketing of advanced, high-speed communications ICs for Ethernet connectivity primarily in the data center, enterprise infrastructure and access markets. Aquantia Corp. is headquartered in San Jose, California.
Aquantia Corp. (NYSE:AQ)’s Financial Outlook
The 8 analysts offering 12-month price forecasts for Aquantia Corp have a median target of 14.50, with a high estimate of 21.00 and a low estimate of 12.50. The median estimate represents a +65.34% increase from the last price of 8.77.
Aquantia Corp. is estimated to report earnings on 02/14/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.05. The reported EPS for the same quarter last year was $-0.06.
According to Zacks Investment Research, Aquantia Corp. has a Consensus Recommendation of 1.57. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 1.74% and closed its last trading session at $8.77. The company has the market capitalization of $300.37 Million. The stock has 52-week high of $18.49 and 52-Week low of $7.08. The firm touched its 52-Week high on 18.49 and 52-Week low on 7.08. The company has volume of 165405 shares. The company has a total of 34.25 Million shares outstanding.
Aquantia Corp. (NYSE) in the last quarter reported its actual EPS of $0/share where the analyst estimated EPS was $0.01/share. The difference between the actual and Estimated EPS is $-0.01. This shows a surprise factor of -100 percent.
The company has YTD performance of 0 percent. Beta for Aquantia Corp. stands at 0 while its ATR (average true range) is 0.4. The company has Weekly Volatility of 3.40%% and Monthly Volatility of 4.58%%.
Aquantia Corp. has distance from 20-day Simple Moving Average (SMA20) of 2.59%, Distance from 50-Day Simple Moving Average of -5.08 percent and Distance from 200-Day Simple Moving Average of -25.92%.
The Company currently has ROA (Return on Assets) of -4.8 percent, Return on Equity (ROE) of -5.7 Percent and Return on Investment (ROI) of -3.1% with Gross margin of 57.5 percent and Operating & Profit margin of -5.2% and -4.5% respectively.